Endocytosis in gene therapy with non-viral vectors
- PMID: 27141862
- DOI: 10.1007/s10354-016-0450-5
Endocytosis in gene therapy with non-viral vectors
Abstract
Gene therapy or the delivery of genetic material can be carried out not only with viral vectors, but with non-viral vectors too. Although the use of non-viral carriers is safer, this approach has generally been poorer in terms of transfection efficiency. In order to improve the transfection rates, it is important to exactly know the path that the nanoparticles go through. In this way, we can understand the reason why some of these vectors fail or are successful in their duties. This review aims to summarize the different stages and barriers that nanocarriers have to overcome during endocytosis so as to reach the cytoplasm, in the case of RNA, or the nucleus, in the case of DNA. In addition, different strategies that could be employed to improve the success of the carriers in each stage are suggested.
Keywords: DNA; Endocytosis; Gene therapy; Nanoparticles; Non-viral vectors; RNA.
Similar articles
-
Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.Eur J Pharm Biopharm. 2004 Jan;57(1):1-8. doi: 10.1016/s0939-6411(03)00155-3. Eur J Pharm Biopharm. 2004. PMID: 14729076 Review.
-
Pharmaceutical strategies enhancing cell penetration efficiencies of non-viral gene delivery systems.Curr Gene Ther. 2009 Aug;9(4):267-90. doi: 10.2174/156652309788921053. Curr Gene Ther. 2009. PMID: 19534654 Review.
-
Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.Curr Gene Ther. 2012 Apr 1;12(2):92-102. doi: 10.2174/156652312800099625. Curr Gene Ther. 2012. PMID: 22348553 Review.
-
Regulation of endocytosis by non-viral vectors for efficient gene activity.J Biomed Nanotechnol. 2014 Jan;10(1):67-80. doi: 10.1166/jbn.2014.1682. J Biomed Nanotechnol. 2014. PMID: 24724499 Review.
-
Lipid nanoparticles for gene delivery.Adv Genet. 2014;88:13-36. doi: 10.1016/B978-0-12-800148-6.00002-X. Adv Genet. 2014. PMID: 25409602 Free PMC article. Review.
Cited by
-
Cationic Materials for Gene Therapy: A Look Back to the Birth and Development of 2,2-Bis-(hydroxymethyl)Propanoic Acid-Based Dendrimer Scaffolds.Int J Mol Sci. 2023 Nov 6;24(21):16006. doi: 10.3390/ijms242116006. Int J Mol Sci. 2023. PMID: 37958989 Free PMC article. Review.
-
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson's Disease.Cells. 2020 Mar 31;9(4):841. doi: 10.3390/cells9040841. Cells. 2020. PMID: 32244357 Free PMC article. Review.
-
Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.Molecules. 2021 Oct 1;26(19):5976. doi: 10.3390/molecules26195976. Molecules. 2021. PMID: 34641519 Free PMC article. Review.
-
Improving transgene expression and CRISPR-Cas9 efficiency with molecular engineering-based molecules.Clin Transl Med. 2020 Oct;10(6):e194. doi: 10.1002/ctm2.194. Clin Transl Med. 2020. PMID: 33135339 Free PMC article.
-
Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers.Front Pharmacol. 2018 Aug 21;9:971. doi: 10.3389/fphar.2018.00971. eCollection 2018. Front Pharmacol. 2018. PMID: 30186185 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical